A novel circulating miRNA panel for non-invasive ovarian cancer diagnosis and prognosis

BACKGROUND: Ovarian cancer (OC) is an aggressive disease, primarily diagnosed in late stages with only 20% of patients surviving more than 5 years after diagnosis. There is a pending need to improve current diagnostics and prognostics. METHODS: In this study, we investigated total circulating cell-f...

Descripción completa

Detalles Bibliográficos
Autores principales: Gahlawat, Aoife Ward, Witte, Tania, Haarhuis, Lisa, Schott, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553930/
https://www.ncbi.nlm.nih.gov/pubmed/35931806
http://dx.doi.org/10.1038/s41416-022-01925-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553930/
https://www.ncbi.nlm.nih.gov/pubmed/35931806
http://dx.doi.org/10.1038/s41416-022-01925-0

Ejemplares similares